Author's reply to: Norepinephrine antagonists and cancer risk

International Journal of Cancer

Volumn 128, Issue 3, 2011, Pages 738-739

  Fitzgerald, Paul J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adrenoceptor; atenolol; clonidine; epidemiology; hypertension; norepinephrine; prazosin; propranolol

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN; PROPRANOLOL; RESVERATROL;

BREAST CANCER; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; DRUG EFFECT; HUMAN; HYPERTENSION; LETTER; LONG TERM CARE; METASTASIS INHIBITION; NORADRENERGIC SYSTEM; OBESITY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION;

EID: 78649837505     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25382     Document Type: Letter

References (6)

1. Fitzgerald PJ,. Is norepinephrine an etiological factor in some types of cancer? Int J Cancer 2009; 124: 257-63.
2. Goon PK, Stonelake PS, Lip GY,. Hypertension, anti-hypertensive therapy and neoplasia. Curr Pharm Des 2007; 13: 2539-44.
3. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M,. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-78.
4. Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE,. Aspirin intake and survival after breast cancer. J Clin Oncol 2010; 28: 1467-72.
5. Brisdelli F, D'Andrea G, Bozzi A,. Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr Drug Metab 2009; 10: 530-46.
6. Guo K, Ma Q, Wang L, Hu H, Li J, Zhang D, Zhang M,. Norepinephrine- induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol Rep 2009; 22: 825-30.